Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of the Xpert BCR-ABL Ultra Assay on the GeneXpert Instrument Systems

NCT03421626 is registered in ClinicalTrials.gov with Cepheid as lead sponsor.

NCT NCT03421626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03421626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of the Xpert BCR-ABL Ultra Assay on the GeneXpert Instrument Systems
Lead sponsor
Cepheid
Phase
Observational
Overall status
Completed
Start date
November 8, 2017
Completion date
August 20, 2018
Enrollment
266 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, myelogenous, chronic